June 28, 2024 in News Article Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
June 26, 2024 in News Article SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
February 17, 2023 in News Article Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
July 26, 2022 in News Article Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
June 9, 2022 in News Article Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test
April 21, 2022 in News Article Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results
March 28, 2022 in News Article Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
March 24, 2022 in News Article Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer
